Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. PHOENIX, Arizona – 85-year old Howard Morrow enjoys days with his wife Joyce and dog Oliver. Now, he gets injections to slow the disease. University of Arizona researcher Brian McKay's team ...

    2. More than 9000 people nationwide are still having to wait significantly longer than intended for their follow-up eye care.

    3. About Lucentis Lucentis (ranibizumab) is used for the treatment of individuals with neovascular (or wet) age-related macular degeneration (or AMD), macular edema after retinal ...

    4. The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of September 20, 2017..

    5. French biotech company Neovacs is confident that its experimental drug to treat lupus could grab significant market share from standard treatments of the auto-immune disease, its chief executive ...

    6. Topline results are expected in 2018. Updates on Molecular Partners' clinical development timelines. This event is intended for institutional investors, sell-side analysts, investment bankers ...

    7. Greenville, Pennsylvania

    8. Ophthotech Corporation (NASDAQ:OPHT) initiates an open-label Phase 2a clinical trial of Zimura (avacincaptad pegol), the Company’s complement factor C5 inhibitor, in patients with wet age-related ...

    9. The Pahrump Senior Center is hosting a special event today. Officials with Easter Seals Nevada will be on site from 9 a.m. to 3 p.m. providing daily living items and information for area seniors ...

    10. American seniors are getting healthier overall, but the well-educated, rich and white are seeing the greatest gains, a new study finds.

    1. 123440 results